Relation to donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease

Journal of the American College of Cardiology

Volumn 29, Issue 3, 1997, Pages 623-629

  Gao, Shao Zhou ^a   Hunt, Sharon A ^a   Alderman, Edwin L ^a   Liang, David ^a   Yeung, Alan C ^a   Schroeder, John S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DILTIAZEM; PREDNISONE;

ADULT; AGE; ALLOGRAFT; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DONOR; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ULTRASOUND;

ADOLESCENT; ADULT; AGE FACTORS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DISEASE PROGRESSION; HEART TRANSPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0031049737     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00521-9     Document Type: Article

References (22)

1. Griepp RB, Stinson EB, Clark DA, Dong E, Shumway NE. The cardiac donor. Surg Gynecol Obstet 1971;133:792-8.
2. DeBakey ME, Deitrich EB, Glick G, et al. Human cardiac transplantation: clinical experience. J Thorac Cardiovasc Surg 1969;58:303-17.
3. English TAH, Spratt P, Wallwork J, Cory-Pearce R, Wheeldon D. Selection and procurement of hearts for transplantation. BMJ 1984;288:1889-91.
4. Hosenpud JD, Novick RJ, Breen TJ, Daily OP. The registry of the International Society for Heart and Lung Transplantation: eleventh annual report - 1994. J Heart Lung Transplant 1994;13:561-70.
5. Schüler S, Warnecke H, Loebe M, Fleck E, Hetzer R. Extended donor age in cardiac transplantation. Circulation 1989;80 Suppl III:III-133-9.
6. Menkis AH, Novick RJ, Kostuk WJ, et al. Successful use of the "unacceptable" heart donor. J Heart Lung Transplant 1991;10:28-32.
7. Mulvagh SL, Thornton B, Frazier OH, et al. The older cardiac transplant donor: relation to graft function and recipient survival longer than 6 years. Circulation 1989;80 Suppl III, Pt. 2:III-126-32.
8. Pflugfelder PW, Singh NR, McKenzie FN, Menkis AH, Novick RJ, Kostuk WJ. Extending cardiac allograft ischemic time and donor age: effect on survival and long-term cardiac function. J Heart Lung Transplant 1991;10: 394-400.
9. Schüler S, Matschke K, Loebe M, Hummel M, Fleck E, Hetzer R. Coronary artery disease in patients with hearts from older donors: morphologic features and therapeutic implications. J Heart Lung Transplant 1993;12: 100-9.
10. St. Goar FG, Pinto FJ, Alderman EL, et al. Detection of coronary atherosclerosis in young adult hearts using intravascular ultrasound. Circulation 1992;86:756-63.
11. St. Goar FG, Pinto FJ, Alderman EL, et al. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of "angiographically silent" intimai thickening. Circulation 1992;85:979-87.
12. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561-6.
13. Merigan TC, Renlund DG, Keay S, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 1992;326:1182-6.
14. Gao SZ, Hunt SA, Schroeder JS, Alderman EL, Hill IR, Stinson EB. Early development of accelerated graft coronary artery disease: risk factors and course. J Am Coll Cardiol 1996;28:673-9.
15. Johnson DE, Gao SZ, Schroeder JS, DeCampli WM, Billingham ME. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant 1989;8:349-59.
16. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995;333:621-7.
17. Pflugfelder PW, Boughner DR, Rudas L, Kostuk WJ. Enhanced detection of cardiac allograft arterial disease with intracoronary ultrasonographic imaging. Am Heart J 1993;125:1583-91.
18. Botas J, Pinto FJ, Chenzbraun A, et al. Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy; an intravascular ultrasound study. Circulation 1995;92:1126-32.
19. Tuzcu EM, Hobbs RE, Rincon G, et al. Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation: insights with intravascular ultrasound. Circulation 1995;91:1706-13.
20. Schroeder JS, Gao S-Z, Alderman EL, et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart transplant recipients. N Engl J Med 1993;328:164-70.
21. Schroeder JS, Gao S-Z, Alderman EL, Hunt SA, Hill I, Stinson EB. Prevention of transplant coronary vascular disease with diltiazem [abstract]. J Am Coll Cardiol 1994;23:231A.
22. Mehra MR, Ventura HD, Smart FW, Collins TJ, Ramee SR, Stapleton DD. An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy. Am J Cardiol 1995;75:853-7.